Title : Effects of sacubitril/valsartan on B-type natriuretic peptide circulating levels and loop diuretic dose in a case series of stabilized heart failure patients with left ventricular ejection fraction ≤35.

Pub. Date : 2019 May

PMID : 30895809






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sacubitril/valsartan, an angiotensin receptor neprilysin inhibitor, was shown to improve outcome in patients with heart failure (HF) and reduced left ventricular ejection fraction (LVEF). Valsartan membrane metalloendopeptidase Homo sapiens